In 2022, the production value of quasi-drugs in South Korea lay at around 2.14 trillion South Korean won. This represents a decrease of around 8.5 percent compared to the previous year. This made 2020 the year with the highest production value by far within the decade.
Value of quasi-drugs produced in South Korea from 2012 to 2022 (in trillion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Quasi-drug import value in South Korea 2012-2022
- Premium Statistic Quasi-drug market size in South Korea 2012-2022
- Premium Statistic Biopharmaceutical production value in South Korea 2012-2022
- Premium Statistic Herbal raw material production value in South Korea 2012-2022
- Premium Statistic Biopharmaceutical market size in South Korea 2012-2022
- Basic Statistic Items for management of psoriasis dispensed in England 2022, by select chemical
- Basic Statistic Leading orphan drugs in development based on net present value 2023
- Premium Statistic Top 10 companies by global revenue from orphan drugs 2028
- Premium Statistic Herbal raw material export value in South Korea 2012-2022
- Premium Statistic Herbal raw material import value in South Korea 2012-2022
About the region
10
- Premium Statistic Medical device export value from South Korea 2012-2022
- Premium Statistic Medical device import value in South Korea 2012-2022
- Premium Statistic Medical device market size in South Korea 2012-2022
- Premium Statistic Medical device import value in South Korea 2022, by region
- Premium Statistic Successful medical device manufacturers South Korea 2022, based on production value
- Premium Statistic Number of medical device patent applications South Korea 2010-2020
- Premium Statistic Distribution of medical device patent applications South Korea 2020, by type
- Premium Statistic Pharmaceutical import value in South Korea 2012-2022
- Premium Statistic Biopharmaceuticals export value from South Korea 2012-2022
- Premium Statistic Biopharmaceutical import value in South Korea 2012-2022
Selected statistics
4
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
Other regions
10
- Premium Statistic Pharmacies' revenue in Italy 2022, by type of product
- Basic Statistic Oregon's medical cannabis sales value U.S. 2018-2024
- Basic Statistic Pharmacy revenue share in Sweden 2023, by type of product
- Premium Statistic Number of pharmaceuticals on China's national reimbursement drug list
- Premium Statistic Leading orphan designations in the EU by indication 2015
- Premium Statistic Median length of orphan and non-orphan drugs in phase III trial 2015
- Premium Statistic OTC drugs market shipment value in Japan 2010-2019
- Basic Statistic Vermont's medical cannabis sales value U.S. 2018-2024
- Basic Statistic Illinois' medical cannabis sales value U.S. 2018-2024
- Premium Statistic Massachusetts' medical cannabis spending 2018-2024
Related statistics
10
- Premium Statistic Pharmaceutical export value from South Korea 2012-2022
- Premium Statistic Herbal raw material market size in South Korea 2012-2022
- Premium Statistic Medical device export value South Korea 2022, by destination
- Premium Statistic Medical device import value South Korea 2022, by country
- Premium Statistic Medical devices export value South Korea 2022, by product
- Premium Statistic Medical devices import value South Korea 2022, by product
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
Further related statistics
10
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Walgreens operating income in the U.S. 2005-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Pfizer's ad spending 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Grape crush volume share in California for the production of wine 2022, by variety
- Amount of grapes crushed in California for wine production 2000-2022, by wine variety
- Amphetamine users worldwide by region 2010-2020
Further Content: You might find this interesting as well
Statistics
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Walgreens operating income in the U.S. 2005-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Pfizer's ad spending 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Grape crush volume share in California for the production of wine 2022, by variety
- Amount of grapes crushed in California for wine production 2000-2022, by wine variety
- Amphetamine users worldwide by region 2010-2020
MFDS (South Korea). (December 28, 2023). Value of quasi-drugs produced in South Korea from 2012 to 2022 (in trillion South Korean won) [Graph]. In Statista. Retrieved April 19, 2024, from https://www.statista.com/statistics/780977/south-korea-quasi-drug-production-value/
MFDS (South Korea). "Value of quasi-drugs produced in South Korea from 2012 to 2022 (in trillion South Korean won)." Chart. December 28, 2023. Statista. Accessed April 19, 2024. https://www.statista.com/statistics/780977/south-korea-quasi-drug-production-value/
MFDS (South Korea). (2023). Value of quasi-drugs produced in South Korea from 2012 to 2022 (in trillion South Korean won). Statista. Statista Inc.. Accessed: April 19, 2024. https://www.statista.com/statistics/780977/south-korea-quasi-drug-production-value/
MFDS (South Korea). "Value of Quasi-drugs Produced in South Korea from 2012 to 2022 (in Trillion South Korean Won)." Statista, Statista Inc., 28 Dec 2023, https://www.statista.com/statistics/780977/south-korea-quasi-drug-production-value/
MFDS (South Korea), Value of quasi-drugs produced in South Korea from 2012 to 2022 (in trillion South Korean won) Statista, https://www.statista.com/statistics/780977/south-korea-quasi-drug-production-value/ (last visited April 19, 2024)
Value of quasi-drugs produced in South Korea from 2012 to 2022 (in trillion South Korean won) [Graph], MFDS (South Korea), December 28, 2023. [Online]. Available: https://www.statista.com/statistics/780977/south-korea-quasi-drug-production-value/